Insider Buying: Clover Health Investments, Corp. (NASDAQ:CLOV) Director Purchases 17,085 Shares of Stock

Clover Health Investments, Corp. (NASDAQ:CLOV - Get Free Report) Director Anna U. Loengard bought 17,085 shares of the business's stock in a transaction dated Thursday, May 16th. The shares were acquired at an average cost of $0.96 per share, for a total transaction of $16,401.60. Following the transaction, the director now directly owns 15,600 shares in the company, valued at approximately $14,976. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Clover Health Investments Price Performance

Shares of NASDAQ CLOV traded up $0.01 during midday trading on Monday, hitting $0.90. 4,753,775 shares of the company's stock were exchanged, compared to its average volume of 8,658,277. Clover Health Investments, Corp. has a twelve month low of $0.61 and a twelve month high of $1.63. The company has a market cap of $444.56 million, a PE ratio of -2.63 and a beta of 1.88. The firm's fifty day simple moving average is $0.76 and its 200-day simple moving average is $0.89.

Clover Health Investments (NASDAQ:CLOV - Get Free Report) last issued its earnings results on Tuesday, March 12th. The company reported ($0.12) earnings per share for the quarter, topping the consensus estimate of ($0.18) by $0.06. Clover Health Investments had a negative return on equity of 48.07% and a negative net margin of 8.63%. The business had revenue of $510.25 million for the quarter, compared to analyst estimates of $491.20 million. Equities analysts anticipate that Clover Health Investments, Corp. will post -0.2 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently modified their holdings of CLOV. Jupiter Asset Management Ltd. boosted its stake in shares of Clover Health Investments by 18.1% in the first quarter. Jupiter Asset Management Ltd. now owns 4,525,079 shares of the company's stock valued at $3,593,000 after buying an additional 692,878 shares in the last quarter. Citigroup Inc. raised its holdings in shares of Clover Health Investments by 4,040.8% in the 3rd quarter. Citigroup Inc. now owns 372,421 shares of the company's stock worth $402,000 after purchasing an additional 363,427 shares during the period. Bayesian Capital Management LP purchased a new position in shares of Clover Health Investments in the 1st quarter worth about $142,000. Turtle Creek Wealth Advisors LLC acquired a new stake in shares of Clover Health Investments in the fourth quarter valued at about $162,000. Finally, Jump Financial LLC acquired a new stake in shares of Clover Health Investments in the fourth quarter valued at about $125,000. 19.77% of the stock is currently owned by hedge funds and other institutional investors.

Clover Health Investments Company Profile

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.